Skip to content

Outcomes in Children With Pre-operative Residual Hearing

Outcomes in Children With Cochlear Implants and Pre-Operative Residual Hearing: Electric Only and Electric-Acoustic Stimulation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03379870
Enrollment
28
Registered
2017-12-20
Start date
2018-05-25
Completion date
2023-12-14
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Disorders in Children, High Frequency Sensorineural Hearing Impairment

Keywords

cochlear implant, electric acoustic stimulation, EAS, hearing loss, pediatric

Brief summary

Purpose: Routine clinical care and pilot study data has shown evidence of postoperative hearing preservation in pediatric cochlear implant (CI) recipients. The primary aim of this study is to investigate speech perception performance in pediatric CI recipients with functional pre-operative hearing. Participants: Two cohorts of CI recipients aged 6 through 17 years who had pre-operative low frequency residual hearing. Subjects in Arm 1 (EAS Arm; electric-acoustic stimulation) will present with a post-operative low frequency pure tone average (125, 250, and 500 Hz) of ≤ 75 dB HL, and those in Arm 2 (FES Arm; full-electric stimulation) will present with a post-operative low frequency pure tone average (LFPTA) that exceeds 75 dB HL. Procedures (methods): Subjects will complete speech perception and quality of life testing during post-operative intervals. Subjects in the EAS Arm will be evaluated with combined electric-acoustic stimulation (EAS). Subjects in FES Arm will be evaluated with FES alone.

Detailed description

As children with more residual hearing are receiving cochlear implants (CIs), there is an opportunity to preserve that hearing and provide combined electric and acoustic stimulation (EAS). The primary aim of this study is to investigate speech perception performance in pediatric CI recipients with functional pre-operative hearing. Specifically, the investigators intend to compare speech understanding using EAS and traditional full electric stimulation. While hearing preservation rates are good, they are not guaranteed. Children with progressive hearing loss may continue to lose hearing, even if they maintain some residual hearing immediately after surgery. As a secondary aim, the investigators intend to study outcomes in children who do not maintain residual hearing and are fit with traditional CI programming methods. Children with more residual hearing are being implanted, and this study design allows validation of outcomes in both populations. Subject enrollment will occur on the initial stimulation date. Those who have maintained a low frequency hearing average of 75 dB HL or better will be fit with a SONNET EAS or SONNET 2 EAS device using combined acoustic and electric stimulation. Those who have not maintained low frequency hearing will be fit with a SONNET EAS or SONNET 2 EAS device using electric stimulation only. Subjects will be followed at regular intervals throughout the year duration of the study and will be tested on measures of speech understanding in quiet, speech understanding in noise, quality of life, and discrimination of prosody or pitch changes.

Interventions

DEVICEElectric Acoustic Speech Processor: Electric-acoustic stimulation fitting

Electric Acoustic Stimulation for children with post-operative residual low frequency hearing averages of 75 dB HL or better,

DEVICEElectric Acoustic Speech Processor: Full-electric stimulation fitting

Electric Stimulation for children with post-operative residual low frequency hearing averages of 75 dB HL or poorer and pre-operative low frequency hearing averages of 75 dB HL or better.

Sponsors

Med-El Corporation
CollaboratorINDUSTRY
University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Months to 215 Months
Healthy volunteers
Yes

Inclusion criteria

* Aged 5 through 17 years * Spoken English as the primary language (speech perception testing conducted in English). * Recipient of a MED-EL SYNCHRONY Cochlear Implant device. * Pre-operative LFPTA of ≤ 75 dB HL. * Willing and able to participate in study procedures. * Realistic parental/patient expectations. * Language skills judged to be adequate enough to perform study tasks.

Exclusion criteria

* Inability to perform open set speech perception due to oral motor delays. * Inability to perform test battery due to behavior or cognitive impairment * Unwilling or unable to participate in study procedures. * Cochlear nerve deficiency. * Anatomical considerations that necessitated surgical modifications such as ossification, incomplete insertion, or placement in scala vestibuli.

Design outcomes

Primary

MeasureTime frameDescription
Mean CNC Word Scores12 months post stimulationThe Consonant Nucleus Consonant (CNC) word list is established as a standard test of speech perception outcomes. Results for EAS and FES Arms at 12 months post stimulation will be compared. Lower scores indicate a poorer outcome and higher scores a better outcome. Scale 0 - 100%
Mean BKB-SIN SNR-50 Scores12 months post-stimulationSentences and babble will be presented from the same speaker. An average score known as the SNR-50 will be obtained in both conditions. The SNR-50 score is an estimate of the signal-to-noise ratio associated with 50% correct based on word-level scoring. Results for EAS and FES listeners at 12 months post stimulation will be compared. In this test, lower scores indicate a better outcome and higher scores a poorer outcome. Scores range from -6 dB to +21 dB.

Secondary

MeasureTime frameDescription
Mean Pediatric SSQ ScoresBaseline, 12 months post-stimulationThe Speech, Spatial, and Qualities of Hearing (SSQ) Scale assesses performance in three domains, hearing speech in quiet and noise environments (9 items), spatial or directional hearing (5 items) and sound qualities (8 items), which address sound segregation and listening effort. Each item is rated on a 11-point scale, with 0 as the lowest possible performance and 10 as the highest. Domain scores represent an average of item ratings. There is a version for children that will be used for this study. Lower scores indicate a poorer outcome, and higher scores a better outcome.
Receptive Language Scores12 months post-stimulationMean receptive language scores as measured by the Oral and Written Language Scales, 2nd edition (OWLS II), comparing pre-operative scores to the 12 month test point for both groups. These tests are normed and reported as scaled scores. T-Scores scores will be compared. Low scores are indicative of a poorer outcome, and higher scores a better outcome. A scores of 100 indicated the population mean with a standard deviation of 15. A score of 85 or poorer is indicative of a receptive language delay.
Articulation Scores12 months post-stimulationMean articulation scores as measured by the Goldman-Fristoe Test of Articulation, 3rd edition (GFTA3), comparing pre-operative scores to the 12 month test point for both groups. These tests are normed and reported as scaled scores. T-Scores scores will be compared. Low scores are indicative of a poorer outcome, and higher scores a better outcome. A score of 100 indicates the population mean with a standard deviation of 15. A score of 85 or poorer is indicative of a articulation delay.
Expressive Language Scores12 months post-stimulationMean expressive language scores as measured by the Oral and Written Language Scales, 2nd edition (OWLS II), comparing pre-operative scores to the 12 month test point for both groups. These tests are normed and reported as scaled scores. T-Scores scores will be compared. Low scores are indicative of a poorer outcome, and higher scores a better outcome. A score of 100 indicates the population mean with a standard deviation of 15. A score of 85 or poorer is indicative of an expressive language delay.

Countries

United States

Participant flow

Participants by arm

ArmCount
EAS Arm
Subjects who receive a CI and present with a post-operative LFPTA of ≤ 75 dB HL. Electric Acoustic Speech Processor: EAS fitting: Electric Acoustic Stimulation for children with post-operative residual low frequency hearing averages of 75 dB HL or better.
14
FES Arm
Subjects with pre-operative low frequency hearing who receive a CI and present with a post-operative LFPTA of \> 75 dB HL. Electric Acoustic Speech Processor: Electric only fitting: Electric Stimulation for children with post-operative residual low frequency hearing averages greater than 75 dB HL and pre-operative low frequency hearing averages of 75 dB HL or better.
11
Total25

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up10
Overall StudyProtocol Violation11

Baseline characteristics

CharacteristicEAS ArmFES ArmTotal
Age, Continuous9.9 years
STANDARD_DEVIATION 3.9
10.5 years
STANDARD_DEVIATION 3.3
10.2 years
STANDARD_DEVIATION 3.6
Post-operative Low Frequency Pure Tone Average (PTA) at Enrollment46.2 Decibels (dB)
STANDARD_DEVIATION 14.5
85.8 Decibels (dB)
STANDARD_DEVIATION 16.4
63.6 Decibels (dB)
STANDARD_DEVIATION 25.1
Pre-operative Low Frequency Pure Tone Average (PTA)29.9 Decibels (dB)
STANDARD_DEVIATION 17.8
57.5 Decibels (dB)
STANDARD_DEVIATION 11.6
43.1 Decibels (dB)
STANDARD_DEVIATION 20.5
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
2 Participants0 Participants2 Participants
Race (NIH/OMB)
Black or African American
4 Participants1 Participants5 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
8 Participants10 Participants18 Participants
Region of Enrollment
United States
14 Participants11 Participants25 Participants
Sex: Female, Male
Female
6 Participants8 Participants14 Participants
Sex: Female, Male
Male
8 Participants3 Participants11 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 160 / 12
other
Total, other adverse events
1 / 160 / 12
serious
Total, serious adverse events
0 / 160 / 12

Outcome results

Primary

Mean BKB-SIN SNR-50 Scores

Sentences and babble will be presented from the same speaker. An average score known as the SNR-50 will be obtained in both conditions. The SNR-50 score is an estimate of the signal-to-noise ratio associated with 50% correct based on word-level scoring. Results for EAS and FES listeners at 12 months post stimulation will be compared. In this test, lower scores indicate a better outcome and higher scores a poorer outcome. Scores range from -6 dB to +21 dB.

Time frame: 12 months post-stimulation

Population: Subjects who completed the 12-month protocol

ArmMeasureValue (MEAN)Dispersion
EAS ArmMean BKB-SIN SNR-50 Scores6.9 Signal to noise ratio (SNR) in decibelsStandard Deviation 9.3
FES ArmMean BKB-SIN SNR-50 Scores5.5 Signal to noise ratio (SNR) in decibelsStandard Deviation 7.7
p-value: 0.529Mixed Models Analysis
Primary

Mean CNC Word Scores

The Consonant Nucleus Consonant (CNC) word list is established as a standard test of speech perception outcomes. Results for EAS and FES Arms at 12 months post stimulation will be compared. Lower scores indicate a poorer outcome and higher scores a better outcome. Scale 0 - 100%

Time frame: 12 months post stimulation

Population: Subjects who completed the 12-month protocol

ArmMeasureValue (MEAN)Dispersion
EAS ArmMean CNC Word Scores71.0 Percent CorrectStandard Deviation 18
FES ArmMean CNC Word Scores68.4 Percent CorrectStandard Deviation 26
p-value: 0.768Mixed Models Analysis
Secondary

Articulation Scores

Mean articulation scores as measured by the Goldman-Fristoe Test of Articulation, 3rd edition (GFTA3), comparing pre-operative scores to the 12 month test point for both groups. These tests are normed and reported as scaled scores. T-Scores scores will be compared. Low scores are indicative of a poorer outcome, and higher scores a better outcome. A score of 100 indicates the population mean with a standard deviation of 15. A score of 85 or poorer is indicative of a articulation delay.

Time frame: 12 months post-stimulation

Population: Data reported for all subjects who completed pre-operative testing.

ArmMeasureGroupValue (MEAN)Dispersion
EAS ArmArticulation ScoresPre-operative86.8 T-scoreStandard Deviation 14.4
EAS ArmArticulation Scores12-months post activation99.3 T-scoreStandard Deviation 20.1
FES ArmArticulation ScoresPre-operative83.6 T-scoreStandard Deviation 23.2
FES ArmArticulation Scores12-months post activation88.3 T-scoreStandard Deviation 18.8
p-value: 0.02Mixed Models Analysis
Secondary

Expressive Language Scores

Mean expressive language scores as measured by the Oral and Written Language Scales, 2nd edition (OWLS II), comparing pre-operative scores to the 12 month test point for both groups. These tests are normed and reported as scaled scores. T-Scores scores will be compared. Low scores are indicative of a poorer outcome, and higher scores a better outcome. A score of 100 indicates the population mean with a standard deviation of 15. A score of 85 or poorer is indicative of an expressive language delay.

Time frame: 12 months post-stimulation

Population: Not all subjects completed pre-operative testing

ArmMeasureGroupValue (MEAN)Dispersion
EAS ArmExpressive Language ScoresPre-operative96.8 T-scoreStandard Deviation 17.2
EAS ArmExpressive Language Scores12-months post activation101.9 T-scoreStandard Deviation 18
FES ArmExpressive Language ScoresPre-operative99.7 T-scoreStandard Deviation 12.2
FES ArmExpressive Language Scores12-months post activation97.6 T-scoreStandard Deviation 22
p-value: 0.007Mixed Models Analysis
Secondary

Mean Pediatric SSQ Scores

The Speech, Spatial, and Qualities of Hearing (SSQ) Scale assesses performance in three domains, hearing speech in quiet and noise environments (9 items), spatial or directional hearing (5 items) and sound qualities (8 items), which address sound segregation and listening effort. Each item is rated on a 11-point scale, with 0 as the lowest possible performance and 10 as the highest. Domain scores represent an average of item ratings. There is a version for children that will be used for this study. Lower scores indicate a poorer outcome, and higher scores a better outcome.

Time frame: Baseline, 12 months post-stimulation

Population: Subjects who completed the 12-month protocol

ArmMeasureGroupValue (MEAN)Dispersion
EAS ArmMean Pediatric SSQ ScoresPre-operative4.5 score on a scaleStandard Deviation 2.3
EAS ArmMean Pediatric SSQ Scores12-months post activation7.1 score on a scaleStandard Deviation 2.1
FES ArmMean Pediatric SSQ ScoresPre-operative4.4 score on a scaleStandard Deviation 2.1
FES ArmMean Pediatric SSQ Scores12-months post activation6.7 score on a scaleStandard Deviation 1.9
p-value: 0.01Mixed Models Analysis
Secondary

Receptive Language Scores

Mean receptive language scores as measured by the Oral and Written Language Scales, 2nd edition (OWLS II), comparing pre-operative scores to the 12 month test point for both groups. These tests are normed and reported as scaled scores. T-Scores scores will be compared. Low scores are indicative of a poorer outcome, and higher scores a better outcome. A scores of 100 indicated the population mean with a standard deviation of 15. A score of 85 or poorer is indicative of a receptive language delay.

Time frame: 12 months post-stimulation

Population: Not all participants were tested pre-operatively

ArmMeasureGroupValue (MEAN)Dispersion
EAS ArmReceptive Language Scores12-months post activation100.1 T-scoreStandard Deviation 16.2
EAS ArmReceptive Language ScoresPre-operatively98.8 T-scoreStandard Deviation 19.5
FES ArmReceptive Language ScoresPre-operatively99.8 T-scoreStandard Deviation 20.3
FES ArmReceptive Language Scores12-months post activation89.7 T-scoreStandard Deviation 22
p-value: >0.069Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026